-
Новости
- ECOSYSTEM
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
273 Записей
-
0 Фото
-
0 Видео
-
Female
-
07/11/2001
-
Читают 0 человек
Недавние обновления
-
Metastases Spinal Tumor Surgery Market Analysis 2034 | Regional Trends
According to a newly published market research report by 24LifeSciences, the global metastases spinal tumor surgery market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.4 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2024–2030.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15287/metastases-spinal-tumor-surgery-marketMetastases Spinal Tumor Surgery Market Analysis 2034 | Regional Trends According to a newly published market research report by 24LifeSciences, the global metastases spinal tumor surgery market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.4 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2024–2030. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15287/metastases-spinal-tumor-surgery-market0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотрВойдите, чтобы отмечать, делиться и комментировать! -
What Is the Future of Pharmaceutical Excipients for Taste Masking Market ? 2026–2034 Outlook
According to a newly published market research report by 24LifeSciences, global pharmaceutical excipients for taste masking market was valued at USD 2.8 billion in 2024 and is projected to reach USD 4.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.9% during the forecast period 20262031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15869/pharmaceutical-excipients-for-taste-masking-marketWhat Is the Future of Pharmaceutical Excipients for Taste Masking Market ? 2026–2034 Outlook According to a newly published market research report by 24LifeSciences, global pharmaceutical excipients for taste masking market was valued at USD 2.8 billion in 2024 and is projected to reach USD 4.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.9% during the forecast period 20262031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15869/pharmaceutical-excipients-for-taste-masking-market0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр -
ICL Implantable Micro Lens Market Size & Share Analysis 2032
According to a newly published market research report by 24LifeSciences, Global ICL Implantable Micro Lens Market was valued at USD 413 million in 2023 and is projected to reach USD 690 million by 2030, growing at a compound annual growth rate (CAGR) of 7.0% during the forecast period 2024–2030.
The ICL implantable micro lens is an advanced vision correction solution designed for patients with moderate to high myopia, hyperopia, and astigmatism. Unlike traditional laser surgery, ICL uses minimally invasive surgery to implant a soft and foldable artificial lens into the eye between the iris and the natural lens. This lens is made of Collamer material, which has extremely high biocompatibility and UV protection, and can improve vision in a long-term and stable manner without changing the structure of the eye.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3826/icl-implantable-micro-lens--global-outlook-and-marketICL Implantable Micro Lens Market Size & Share Analysis 2032 According to a newly published market research report by 24LifeSciences, Global ICL Implantable Micro Lens Market was valued at USD 413 million in 2023 and is projected to reach USD 690 million by 2030, growing at a compound annual growth rate (CAGR) of 7.0% during the forecast period 2024–2030. The ICL implantable micro lens is an advanced vision correction solution designed for patients with moderate to high myopia, hyperopia, and astigmatism. Unlike traditional laser surgery, ICL uses minimally invasive surgery to implant a soft and foldable artificial lens into the eye between the iris and the natural lens. This lens is made of Collamer material, which has extremely high biocompatibility and UV protection, and can improve vision in a long-term and stable manner without changing the structure of the eye. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3826/icl-implantable-micro-lens--global-outlook-and-market0 Комментарии 0 Поделились 4 Просмотры 0 предпросмотр -
Laminins Market Forecast 2026: Revenue Insights
According to a newly published market research report by 24LifeSciences, global laminins market was valued at USD 230.5 million in 2025 and is projected to reach USD 487.2 million by 2034, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 2026-2034.
Laminins are high-molecular-weight glycoproteins forming a critical component of the extracellular matrix. These heterotrimeric proteins (composed of alpha, beta, and gamma chains) serve as biological scaffolds essential for cellular adhesion, differentiation, and tissue development. Their crucial role in embryogenesis, tissue repair, and cell signaling has established laminins as indispensable tools in biomedical research and regenerative medicine.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15312/laminins-marketLaminins Market Forecast 2026: Revenue Insights According to a newly published market research report by 24LifeSciences, global laminins market was valued at USD 230.5 million in 2025 and is projected to reach USD 487.2 million by 2034, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 2026-2034. Laminins are high-molecular-weight glycoproteins forming a critical component of the extracellular matrix. These heterotrimeric proteins (composed of alpha, beta, and gamma chains) serve as biological scaffolds essential for cellular adhesion, differentiation, and tissue development. Their crucial role in embryogenesis, tissue repair, and cell signaling has established laminins as indispensable tools in biomedical research and regenerative medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15312/laminins-market0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр -
Veterinary Automatic Osmometer Market Analysis 2032 | Regional Trends
According to a newly published market research report by 24LifeSciences, global Veterinary Automatic Osmometer market was valued at $38.0 million in 2024 and is projected to reach $64.8 million by 2031, growing at a compound annual growth rate (CAGR) of 8.1% during the forecast period 20252031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/2597/veterinary-automatic-osmometer-market-marketVeterinary Automatic Osmometer Market Analysis 2032 | Regional Trends According to a newly published market research report by 24LifeSciences, global Veterinary Automatic Osmometer market was valued at $38.0 million in 2024 and is projected to reach $64.8 million by 2031, growing at a compound annual growth rate (CAGR) of 8.1% during the forecast period 20252031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/2597/veterinary-automatic-osmometer-market-market0 Комментарии 0 Поделились 6 Просмотры 0 предпросмотр -
Reteplase Market Outlook: Opportunities & Trends
According to a newly published market research report by 24LifeSciences, global reteplase market was valued at USD 10.7 million in 2024 and is projected to reach USD 8 million by 2031, exhibiting a compound annual growth rate (CAGR) of -4.0% during the forecast period.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4534/reteplase-marketReteplase Market Outlook: Opportunities & Trends According to a newly published market research report by 24LifeSciences, global reteplase market was valued at USD 10.7 million in 2024 and is projected to reach USD 8 million by 2031, exhibiting a compound annual growth rate (CAGR) of -4.0% during the forecast period. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4534/reteplase-market0 Комментарии 0 Поделились 6 Просмотры 0 предпросмотр -
Cytochalasin B Market Outlook: Opportunities & Trends
According to a newly published market research report by 24LifeSciences, global Cytochalasin B market was valued at USD 299 million in 2024 and is projected to reach USD 488 million by 2031, growing at a compound annual growth rate (CAGR) of 7.0% during the forecast period 2024-2031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/16026/cytochalasin-b-market
Cytochalasin B Market Outlook: Opportunities & Trends According to a newly published market research report by 24LifeSciences, global Cytochalasin B market was valued at USD 299 million in 2024 and is projected to reach USD 488 million by 2031, growing at a compound annual growth rate (CAGR) of 7.0% during the forecast period 2024-2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/16026/cytochalasin-b-market0 Комментарии 0 Поделились 8 Просмотры 0 предпросмотр -
Global Knee Replacement Product Market to Reach USD 14.82 Billion by 2032 | CAGR 5.2%
According to a newly published market research report by 24LifeSciences, global knee replacement product market was valued at USD 9.35 billion in 2025 and is projected to reach USD 14.82 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 2025-2034.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15030/knee-replacement-product-marketGlobal Knee Replacement Product Market to Reach USD 14.82 Billion by 2032 | CAGR 5.2% According to a newly published market research report by 24LifeSciences, global knee replacement product market was valued at USD 9.35 billion in 2025 and is projected to reach USD 14.82 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 2025-2034. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15030/knee-replacement-product-market0 Комментарии 0 Поделились 26 Просмотры 0 предпросмотр -
Top 10 Companies Leading Metagenomics Sequencing Market Growth
According to a newly published market research report by 24LifeSciences, global metagenomics sequencing market was valued at USD 910 million in 2024 and is projected to reach USD 1.79 billion by 2031, growing at a compound annual growth rate (CAGR) of 10.4% during the forecast period 2025-2031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15470/metagenomics-sequencing-marketTop 10 Companies Leading Metagenomics Sequencing Market Growth According to a newly published market research report by 24LifeSciences, global metagenomics sequencing market was valued at USD 910 million in 2024 and is projected to reach USD 1.79 billion by 2031, growing at a compound annual growth rate (CAGR) of 10.4% during the forecast period 2025-2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15470/metagenomics-sequencing-market0 Комментарии 0 Поделились 29 Просмотры 0 предпросмотр -
Thalassemia Market Forecast 2026: Revenue Insights
According to a newly published market research report by 24LifeSciences, global thalassemia market was valued at USD 3.24 billion in 2024 and is projected to reach USD 5.92 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period 20252031.
Thalassemia, an inherited blood disorder characterized by abnormal hemoglobin production, leads to excessive destruction of red blood cells and chronic anemia. This condition requires lifelong management through blood transfusions, iron chelation therapy, or potentially curative stem cell transplants. Its prevalence is particularly high in Mediterranean, Middle Eastern, and Southeast Asian populations, driving substantial demand for treatment solutions.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15711/thalassemia-marketThalassemia Market Forecast 2026: Revenue Insights According to a newly published market research report by 24LifeSciences, global thalassemia market was valued at USD 3.24 billion in 2024 and is projected to reach USD 5.92 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period 20252031. Thalassemia, an inherited blood disorder characterized by abnormal hemoglobin production, leads to excessive destruction of red blood cells and chronic anemia. This condition requires lifelong management through blood transfusions, iron chelation therapy, or potentially curative stem cell transplants. Its prevalence is particularly high in Mediterranean, Middle Eastern, and Southeast Asian populations, driving substantial demand for treatment solutions. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15711/thalassemia-market0 Комментарии 0 Поделились 52 Просмотры 0 предпросмотр -
What Is the Future of Blotting Systems Market ? 2026–2034 Outlook
According to a newly published market research report by 24LifeSciences, global blotting systems market was valued at USD 869 million in 2024 and is projected to reach USD 1,170 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025-2031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15589/blotting-systems-marketWhat Is the Future of Blotting Systems Market ? 2026–2034 Outlook According to a newly published market research report by 24LifeSciences, global blotting systems market was valued at USD 869 million in 2024 and is projected to reach USD 1,170 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025-2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15589/blotting-systems-market0 Комментарии 0 Поделились 16 Просмотры 0 предпросмотр -
Top 10 Companies Leading Cough Lozenges Market Growth
According to a newly published market research report by 24LifeSciences, global cough lozenges market was valued at USD 1644 million in 2024 and is projected to reach USD 2069 million by 2031, growing at a compound annual growth rate (CAGR) of 3.4% during the forecast period 2024–2031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4788/cough-lozenges-marketTop 10 Companies Leading Cough Lozenges Market Growth According to a newly published market research report by 24LifeSciences, global cough lozenges market was valued at USD 1644 million in 2024 and is projected to reach USD 2069 million by 2031, growing at a compound annual growth rate (CAGR) of 3.4% during the forecast period 2024–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4788/cough-lozenges-market0 Комментарии 0 Поделились 17 Просмотры 0 предпросмотр
Больше